Searches , social queries for GPR18
Search references for GPR18. Phrases containing GPR18
See searches and references containing GPR18!
Search references for GPR18. Phrases containing GPR18
See searches and references containing GPR18!GPR18
Protein-coding gene in the species Homo sapiens
receptor 18 (GPR18) is a protein that in humans is encoded by the GPR18 gene. Along with the other previously orphan receptors GPR55 and GPR119, GPR18 has been
GPR18
Protein-coding gene in the species Homo sapiens
that in humans is encoded by the GPR55 gene. GPR55, along with GPR119 and GPR18, have been implicated as novel cannabinoid receptors. GPR55 was identified
GPR55
Group of receptors to cannabinoid compounds
supports the hypothesis that the N-arachidonoylglycine (NAGly) receptor GPR18 is the molecular identity of the abnormal cannabidiol receptor and additionally
Cannabinoid_receptor
Protein-coding gene in humans
that in humans is encoded by the GPR119 gene. GPR119, along with GPR55 and GPR18, have been implicated as novel cannabinoid receptors. GPR119 is expressed
GPR119
Chemical compound
is a compound which acts as an antagonist at the former orphan receptor GPR18, and is the first selective antagonist characterised for this receptor,
PSB-CB5
Chemical compound
Recently, NAGly has been found to bind to G-protein coupled receptor 18 (GPR18), the putative abnormal cannabidiol receptor. NaGly is an endogenous inhibitor
N-Arachidonylglycine
Cis enantiomer of tetrahydrocannabidiol
enantiomers are psychoactive, while the others retain activity at targets such as GPR18 and GPR55. Abeo-HHC acetate Abn-CBD CBD-DMH Exo-THC Iso-THC HU-211 Perrottetinene
Cis-THC
Pharmaceutical compound
selective agonist for the cannabinoid-like NAGly receptor, also known as GPR18. It has antiinflammatory effects, and has been studied in an animal model
PSB-KD107
Psychoactive drug from the cannabis plant
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabis_(drug)
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
List_of_cannabinoids
Medication for pain and fever
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Paracetamol
Chemical compound
rabbits, which may reflect agonist activity at the NAGly receptor (formally GPR18) that is known to be a target of many structurally related cannabinoids
Cannabicitran
Genus of flowering plants
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabis
Chemical compound
has good selectivity over the related receptor GPR18, with an IC50 of 113nM at GPR55 vs 12500nM at GPR18. However it has poorer selectivity over other
PSB-SB-487
Chemical compound
receptor GPR55, with an IC50 of 6350nM, but has no significant affinity for GPR18. PSB-SB-487 Rempel V, Volz N, Hinz S, Karcz T, Meliciani I, Nieger M, et al
PSB-SB-1202
Chemical compound
receptors which appear to be related to the cannabinoid receptors, particularly GPR18 and GPR55. These previously orphan receptors have been found to be targets
O-1602
Biological system of neurotransmitters
orphan receptors are known to bind endocannabinoids as well, including GPR18, GPR55 (a regulator of neuroimmune function), and GPR119. CB1 has also been
Endocannabinoid_system
Pharmaceutical compound
selective agonist for the cannabinoid-like NAGly receptor, also known as GPR18. It has potential applications in studying the immune system and development
PSB-KK1415
Specific cannabis extract
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Nabiximols
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
ONO-1110
Chemical compound
targets, CID16020046 has not yet been tested against another related receptor GPR18, so its selectivity for GPR55 over this target has not been established
CID16020046
Natural bicyclic sesquiterpene
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Caryophyllene
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
SYT-510
Minor cannabinoid
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabigerol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Vanoglipel
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Monlunabant
Plant species
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabis_sativa
Synthetic cannabinoid
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Nabilone
Chemical compound
related to cannabidiol, which is an antagonist at two former orphan receptors GPR18 and GPR55, that appear to be related to the cannabinoid receptors. O-1918
O-1918
Designer drugs
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Synthetic_cannabinoids
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Magnolol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Oleamide
Drug designed to treat obesity
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Orlistat
Class of chemical compounds
receptor which is now also termed the RVD1 receptor; 3) RvD2 acts through the GPR18 receptor also now termed the RvD2 receptor; and 4) RvE1 and the 18(S) analog
Resolvin
Spice and hallucinogen
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Nutmeg_as_a_drug
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Elcubragistat
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
WOBE437
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Lixosicone
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
JWH-018
Medication and supplement
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Pregnenolone_(medication)
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Endocannabinoid_transporter
Phytocannabinoid discovered in 1940
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabidiol
Species of plant
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabis_ruderalis
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Palmitoylethanolamide
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Pregnenolone
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Deziglipel
Proposed mechanism of cannabis compounds
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Entourage_effect
Psychoactive component of cannabis
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Tetrahydrocannabinol
Mammalian protein found in humans
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabinoid_receptor_1
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Dimethylheptylpyran
Experimental weight loss drug
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
CRB-913
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
IDFP
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabicyclohexanol
Compounds found in cannabis
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabinoid
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Olorinab
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
CUMYL-4CN-BINACA
Naturally-occurring cannabinoid
and A1 adenosine receptors Highest potency at TRPV1 Antagonist at GPR55, GPR18, 5-HT3A, with highest potency as antagonist at TRPM8 Inverse agonist at
Cannabinol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
WIN_55,212-2
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Pravadoline
Chemical compound (fatty acid neurotransmitter)
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Anandamide
Synthetic cannabinoid
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
HU-210
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
AB-5'F-BUTINACA
Synthetic, cannabinoid-like compound
identification of this novel target in microglia as the previously orphan receptor GPR18. Another possible target of abnormal cannabidiol is GPR55, which has also
Abnormal_cannabidiol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Gallocatechol
Species of plant
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Kava
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Z8526711350
Family of proteins
InterPro: IPR005389 GPR132 (GPR132, G2A) InterPro: IPR005388 GPR17 (GPR17, GPRH) GPR18 (GPR18, GPRI) GPR20 (GPR20, GPRK) GPR35 (GPR35) GPR55 (GPR55) Coagulation factor
Rhodopsin-like_receptors
Cellular molecules that help resolve inflammation
blocks pain perception, increases survival after sepsis stimulates GPR32, GPR18, FPR2, inhibits activation of TRPV1 and TRPA1 RvD3 4S,11R,17S-trihydroxy-5Z
Specialized pro-resolving mediators
Specialized_pro-resolving_mediators
Mammalian protein found in humans
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Fatty-acid_amide_hydrolase_1
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Kaempferol
Phytocannabinoid
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabidiorcol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
A-PBITMO
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Firuglipel
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Dronabinol/palmidrol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
MDMB-4en-PINACA
Active metabolite of Δ9-THC
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
11-Hydroxy-THC
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Yangonin
Working on the endocannabinoid neurotransmitters
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabinoidergic
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Honokiol
P49685 6512 GPR15LG HGNC:31428; Q6UWK7 6513 GPR17 HGNC:4471; Q13304 6514 GPR18 HGNC:4472; Q14330 6515 GPR19 HGNC:4473; Q15760 6516 GPR20 HGNC:4475; Q99678
List of human protein-coding genes 3
List_of_human_protein-coding_genes_3
Mammalian protein found in humans
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Cannabinoid_receptor_2
Cannabis sativa L. (marijuana; hemp) used medicinally
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Medical_cannabis
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
MDMB-BINACA
Class of endogenous fatty acid compounds
cannabinoid-receptor dependent behaviors including antinociception and anxiolysis. GPR18, GPR55, GPR92 have also been proposed to be activated by various N-acyl
N-Acylamides
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
JD5037
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
2-Arachidonoylglycerol
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
ZCZ-011
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
ADB-5'Br-BUTINACA
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
VIP36
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Taranabant
Pharmaceutical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Irafamdastat
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
AM-2201
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
LY-2183240
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
ADB-FUBHQUCA
Type of cannabinoidergic drug
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Endocannabinoid_enhancer
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
CUMYL-3TMS-PRINACA
Homologue of tetrahydrocannabinol
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Tetrahydrocannabivarin
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
Leelamine
Chemical compound
BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol ACPA AM251 Anandamide Cannabidiol NADGly
AR-231,453
travel, tourism, insurance
GPR18
GPR18
GPR18
GPR18
GPR18
GPR18
GPR18
GPR18
GPR18
travel, tourism, insurance